- Home
- FDMT vs CLDT Comparison
FDMT vs CLDT Comparison
Compare FDMT & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- CLDT
- Stock Information
- Founded
- FDMT 2013
- CLDT 2009
- Country
- FDMT United States
- CLDT United States
- Employees
- FDMT N/A
- CLDT 17
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- CLDT Real Estate Investment Trusts
- Sector
- FDMT Health Care
- CLDT Real Estate
- Exchange
- FDMT Nasdaq
- CLDT Nasdaq
- Market Cap
- FDMT 420.7M
- CLDT 429.4M
- IPO Year
- FDMT 2020
- CLDT 2010
- Fundamental
- Price
- FDMT $7.88
- CLDT $9.01
- Analyst Decision
- FDMT Strong Buy
- CLDT Buy
- Analyst Count
- FDMT 9
- CLDT 1
- Target Price
- FDMT $46.75
- CLDT $12.00
- AVG Volume (30 Days)
- FDMT 759.8K
- CLDT 553.8K
- Earning Date
- FDMT 11-13-2024
- CLDT 11-07-2024
- Dividend Yield
- FDMT N/A
- CLDT 3.22%
- EPS Growth
- FDMT N/A
- CLDT N/A
- EPS
- FDMT N/A
- CLDT N/A
- Revenue
- FDMT $17,000.00
- CLDT $313,268,000.00
- Revenue This Year
- FDMT N/A
- CLDT N/A
- Revenue Next Year
- FDMT $57.85
- CLDT $3.65
- P/E Ratio
- FDMT N/A
- CLDT N/A
- Revenue Growth
- FDMT N/A
- CLDT 1.77
- 52 Week Low
- FDMT $7.32
- CLDT $7.60
- 52 Week High
- FDMT $36.25
- CLDT $11.32
- Technical
- Relative Strength Index (RSI)
- FDMT 41.01
- CLDT 56.30
- Support Level
- FDMT $8.04
- CLDT $8.56
- Resistance Level
- FDMT $8.96
- CLDT $9.61
- Average True Range (ATR)
- FDMT 0.59
- CLDT 0.27
- MACD
- FDMT 0.16
- CLDT 0.01
- Stochastic Oscillator
- FDMT 37.10
- CLDT 60.84
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.